Souhaitez-vous accéder aux communiqués récents ?

Gentherm reports record Q2 2026 revenue, raises full-year guidance, announces $400M stock repurchase program, and expands medical portfolio.

Gentherm acquires Innovative Medical Equipment, adding ThermaZone thermal therapy technology to expand its medical portfolio and growth opportunities.

Gentherm receives FDA clearance for ThermAffyx™, an integrated patient warming and securement system designed for robotic-assisted surgery.

Gentherm announces Q2 2026 financial results release and conference call for July 23; webcast and replay details available at gentherm.com.

Gentherm earns GM’s 2025 Supplier of the Year Award for the fourth time, recognizing innovation, quality and partnership supporting GM’s global operations.

Gentherm to present at Baird Global Conference on June 3, 2026, with additional investor meetings and webcast available on its IR website.

Gentherm to showcase science‑backed thermal and massage wellness experiences for home and office environments at NeoCon 2026.

Gentherm delivers record Q1 2026 revenue of $394M, progresses Modine combination, expands home and office markets, and advances medical growth.

Gentherm will report its financial results for the first quarter 2026 on Thursday, April 23, 2026.

Gentherm launches new programs with KUKA Home Furnishing in Asia, extending core technologies beyond automotive into home furniture.